Table 4.
Occurrence of PJI (%) over time in knee arthroplasty group and total hip arthroplasty group according to prophylactic antibiotic.
Group | Prophylactic Antibiotic | 1 Month | 3 Months | <1 Year | >1 Year |
---|---|---|---|---|---|
UKA/TKA | Cefuroxime (n = 21), n (%) | 7 (33.3) | 5 (23.8) | 5 (23.8) | 4 (19.1) |
Non-cefuroxime (n = 3), n (%) | 1 (33.3) | 0 (0.0) | 0 (0.0) | 2 (66.7) | |
THA | Cefuroxime (n = 61), n (%) | 33 (54.1) | 12 (36.4) | 2 (3.3) | 14 (23.0) |
Non-cefuroxime (n = 6), n (%) | 3 (50.0) | 1 (16.7) | 2 (33.3) | 0 (0.0.) |
TKA, total knee arthroplasty; UKA, unicompartmental knee arthroplasty; THA, total hip arthroplasty; n, number.